Targeted Medical Pharma, Inc., a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, has announced the appointment of William B. Horne as the company's Chief Financial Officer.
Horne will oversee all aspects of the company's fiscal operations and financial reporting.
"I am very pleased to have William join our growing management team," said William Shell, M.D., the company's CEO and Chief Science Officer. "His leadership and financial experience in the public and private healthcare sectors is a tremendous asset for Targeted Medical Pharma as we continue to execute on our growth strategy, driven by the increasing demand for cost-effective therapeutic alternatives such as medical foods across the healthcare sector."
Targeted Medical Pharma said that Horne brings to the company a combination of experience in both early stage and mature environments with a 20-year record of success at managing corporate financial operations for fast-growing private and public companies. Horne previously held the position of CFO at various companies, including OptimisCorp, a privately held healthcare technology company, and Patient Safety Technologies, Inc., a publicly traded medical device company. He also held supervisory positions at Price Waterhouse.
((Comments on this story may be sent to firstname.lastname@example.org))